130 related articles for article (PubMed ID: 12521946)
1. Evidence for association of coronary sinus levels of hepatocyte growth factor and collateralization in human coronary disease.
Lenihan DJ; Osman A; Sriram V; Aitsebaomo J; Patterson C
Am J Physiol Heart Circ Physiol; 2003 May; 284(5):H1507-12. PubMed ID: 12521946
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes.
Heeschen C; Dimmeler S; Hamm CW; Boersma E; Zeiher AM; Simoons ML;
Circulation; 2003 Feb; 107(4):524-30. PubMed ID: 12566361
[TBL] [Abstract][Full Text] [Related]
3. Serum hepatocyte growth factor predicts ventricular remodeling following myocardial infarction.
Soeki T; Tamura Y; Shinohara H; Sakabe K; Onose Y; Fukuda N
Circ J; 2002 Nov; 66(11):1003-7. PubMed ID: 12419930
[TBL] [Abstract][Full Text] [Related]
4. Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease.
Soeki T; Tamura Y; Shinohara H; Tanaka H; Bando K; Fukuda N
Heart Vessels; 2000; 15(3):105-11. PubMed ID: 11289497
[TBL] [Abstract][Full Text] [Related]
5. Obesity is associated with increased levels of circulating hepatocyte growth factor.
Rehman J; Considine RV; Bovenkerk JE; Li J; Slavens CA; Jones RM; March KL
J Am Coll Cardiol; 2003 Apr; 41(8):1408-13. PubMed ID: 12706940
[TBL] [Abstract][Full Text] [Related]
6. Increased angiogenic growth factor in cyanotic congenital heart disease.
Himeno W; Akagi T; Furui J; Maeno Y; Ishii M; Kosai K; Murohara T; Kato H
Pediatr Cardiol; 2003; 24(2):127-32. PubMed ID: 12360391
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor is a major mediator in heparin-induced angiogenesis.
Okada M; Matsumori A; Ono K; Miyamoto T; Takahashi M; Sasayama S
Biochem Biophys Res Commun; 1999 Feb; 255(1):80-7. PubMed ID: 10082659
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma.
Iwasaki T; Hamano T; Ogata A; Hashimoto N; Kitano M; Kakishita E
Br J Haematol; 2002 Mar; 116(4):796-802. PubMed ID: 11886383
[TBL] [Abstract][Full Text] [Related]
10. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription.
Reisinger K; Kaufmann R; Gille J
J Cell Sci; 2003 Jan; 116(Pt 2):225-38. PubMed ID: 12482909
[TBL] [Abstract][Full Text] [Related]
11. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.
Van Belle E; Witzenbichler B; Chen D; Silver M; Chang L; Schwall R; Isner JM
Circulation; 1998 Feb; 97(4):381-90. PubMed ID: 9468212
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
[TBL] [Abstract][Full Text] [Related]
13. Serial changes in serum VEGF and HGF in patients with acute myocardial infarction.
Soeki T; Tamura Y; Shinohara H; Tanaka H; Bando K; Fukuda N
Cardiology; 2000; 93(3):168-74. PubMed ID: 10965088
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma.
Sezer O; Jakob C; Eucker J; Niemöller K; Gatz F; Wernecke K; Possinger K
Eur J Haematol; 2001 Feb; 66(2):83-8. PubMed ID: 11168514
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.
Banai S; Jaklitsch MT; Shou M; Lazarous DF; Scheinowitz M; Biro S; Epstein SE; Unger EF
Circulation; 1994 May; 89(5):2183-9. PubMed ID: 7514110
[TBL] [Abstract][Full Text] [Related]
17. Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease.
Fleisch M; Billinger M; Eberli FR; Garachemani AR; Meier B; Seiler C
Circulation; 1999 Nov; 100(19):1945-50. PubMed ID: 10556219
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of hepatocyte growth factor in the heart in patients with coronary artery disease: implication for coronary arteriosclerosis.
Watanabe K; Fukuda H; Sueda S; Funada J; Kitakaze M; Sekiya M
Cardiovasc Drugs Ther; 2001 Mar; 15(2):147-53. PubMed ID: 11669408
[TBL] [Abstract][Full Text] [Related]
19. Humoral and cellular factors responsible for coronary collateral formation.
Sherman JA; Hall A; Malenka DJ; De Muinck ED; Simons M
Am J Cardiol; 2006 Nov; 98(9):1194-7. PubMed ID: 17056326
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor in children with congenital heart disease.
Ootaki Y; Yamaguchi M; Yoshimura N; Oka S; Yoshida M; Hasegawa T
Ann Thorac Surg; 2003 May; 75(5):1523-6. PubMed ID: 12735573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
